Proposed registration of Serenade Opti Biofungicide containing the new active constituent, Bacillus amyloliquefaciens strain QST 713

The APVMA is considering an application for the registration of Serenade Opti Biofungicide containing the new active constituent, Bacillus amyloliquefaciens strain QST 713. The product is to be registered for the control of botrytis bunch rot in grapevines.

We invite comment from 12 December 2017 to 9 January 2018 on whether the application for registration of Serenade Opti Biofungicide containing the new active constituent, Bacillus amyloliquefaciens strain QST 713 should be granted.

The APVMA is able to consider comments relating to the legislative grounds for registration, including:

• occupational health and safety
• public health
• chemistry and manufacture
• residues in food
• environmental safety
• trade
• efficacy and target crop safety

Download the Public Release Summary for the proposed registration of Serenade Opti Biofungicide containing the new active constituent, Bacillus amyloliquefaciens strain QST 713

For more information, see page 45 of Gazette No. 25, 12 December 2017. 

Please send your written submission by email, post or fax to:

Case Management and Administration Unit
Australian Pesticides and Veterinary Medicines Authority
P O Box 6182
Kingston ACT 2604

Phone: +61 2 6210 4701
Fax: +61 2 6210 4721
Email: enquiries@apvma.gov.au